Page 23 - Read Online

Murray Primary circulating prostate cells

phase ii trial: TBCRC 019. Clin Cancer Res 2015;21:2771-9. Escudier B, Cathelineau X, Rozet F, Vallancien G, Sabatier L,
82. Molloy TJ, Devriese LA, Helgason HH, Bosma AJ, Hauptmann M, Soria JC. High detection rate of circulating tumor cells in blood of
Voest EE, Schellens JH, van’t Veer LJ. A multimarker qPCR-based patients with prostate cancer using telomerase activity. Ann Oncol
platform for the detection of circulating tumor cells in patients with 2007;18:518-21.
early-stage breast cancer. Br J Cancer 2011;104:1913-9. 93. Murray NP, Reyes E, Fuentealba C, Jacob O. Efficacy of using
83. Ignatiadis M, Kallergi G, Ntoulia M, Perraki M, Apostolaki S, sequential primary circulating prostate cell detection for initial
Kafousi M, Chlouverakis G, Stathopoulos E, Lianidou E, Georgoulias prostate biopsy in men suspected of prostate cancer. Asian Pac J
V, Mavroudis D. Prognostic value of the molecular detection of Cancer Prev 2016;17:3385-90.
circulating tumor cells using a multi-marker reverse transcription- 94. Murray NP, Reyes E, Orellana N, Fuentealba C, Dueñas R. A
PCR assay for cytokeratin 19, mammaglobin A, and HER2 in early comparative performance analysis of total PSA, percentage free
breast cancer. Clin Cancer Res 2008;14:2593-600. PSA, PSA velocity, and PSA density versus the detection of primary
84. Strati A, Markou A, Parisi C, Politaki E, Mavroudis D, Georgoulias V, circulating prostate cells in predicting initial prostate biopsy findings
Lianidou E. (2011) Gene expression profile of circulating tumor cells in Chilean men. Biomed Res Int 2014;2014:676572.
in breast cancer by RT-PCR. BMC Cancer 2011;11:422. 95. Murray NP, Reyes E, Fuentealba C, Orellana N, Morales F, Jacob O.
85. Obermayr E, Sanchez-Cabo F, Tea MK, Singer CF, Krainer M, Fischer Comparison of the formula of PSA, age, prostate volume and race
MB, Sehouli J, Reinthaller A, Horvat R, Heinze G, Tong D, Zeillinger versus PSA density and the detection of primary malignant circulating
R. Assessment of a six-gene panel for the molecular detection of prostate cells in predicting a positive initial prostate biopsy in Chilean
circulating tumor cells in the blood of female cancer patients. BMC men with suspicion of prostate cancer. Asian Pac J Cancer Prev
Cancer 2010;10:666. 2015;16:5365-70.
86. Davis JW, Nakanishi H, Kumar VS, Bhadkamkar VA, McCormack 96. Murray NP, Reyes E, Fuentealba C, Orellana N, Jacob O, Badilla
R, Fritsche HA, Handy B, Gornet T, Babaian RJ. Circulating tumor S. Head to Head comparison of the Montreal Nomagram with the
cells in peripheral blood samples from patients with increased serum detection of primary malignant circulating prostate cells to predict
prostate specific antigen: initial results in early prostate cancer. J Urol prostate cancer at initial biopsy in Chilean men with suspicion of
2008;179:2187-91. prostate cancer. Urol Onc 2015;33:e19-25.
87. Thalgott M, Rack B, Mauerer T, Souvatzoglou M, Eiber M, Kreß 97. Murray NP, Reyes E, Fuentealba C, Orellana N, Jacob O. Primary
V, Heck MM, Andergassen U, Nawroth R, Gschwend JE, Retz M.
Detection of circulating tumor cells in different stages of prostate circulating prostate cells are not detected in men with low grade small
volume prostate cancer. J Oncol 2014;2014:612674.
cancer. J Cancer Res Clin Oncol 2013;139:755-63.
88. Helo P, Cronin AM, Danila DC, Wenske S, Gonzalez-Espinoza 98. Ennis RD, Katz AE, de Vries GM, Heitjan DF, O’Toole KM, Rubin M,
R, Anand A, Koscuiszka M, Väänänen RM, Pettersson K, Chun Buttyan R, Benson MC, Schiff PB. Detection of circulating prostate
FK, Steuber T, Huland H, Guillonneau BD, Eastham JA, Scardino carcinoma cells via an enhanced RT-PCR assay in patients with early
PT, Fleisher M, Scher HI, Lilja H. Circulating prostate tumor cells stage prostate carcinoma. Independence from other pretreatment
detected by RT-PCR in men with localized or castration refractory characteristics. Cancer 1997;79:2402-8.
prostate cancer: concordance with CellSearch assay and association 99. Eschwège P, Moutereau S, Droupy S, Douard R, Gala JL, Benoit G,
with bone metastasis and survival. Clin Chem 2009;55:765-73. Conti M, Manivet P, Loric S. Prognostic value of prostate circulating
89. Loh J, Jovanovic L, Lehman M, Capp A, Pryor D, Harris M, Nelson C, cells detection in prostate cancer patients: a prospective study. Br J
Martin J. Circulating tumor cell detection in high risk non-metastatic Cancer 2009;100:608-10.
prostate cancer. J Cancer Res Clin Oncol 2014;140:2157-62. 100. Murray NP, Aedo S, Reyes E, Fuentealba C, Jacob O. Outcome of
90. Kolostova K, Broul M, Schraml J, Cegan M, Matkowski R, Fiutowski radical prostatectomy in primary circulating prostate cell negative
M, Bobek V. CTCs in localized prostate cancer: isolation, cultivation prostate cancer. Ecancermedicalscience 2016;10:671.
in vitro and relationship to T-stage and Gleason score. Anticancer Res 101. Meyer CP, Pantel K, Tennstedt P, Stroelin P, Schlomm T, Heinzer
2014;34:3641-6. H, Riethdorf S, Steuber T. Limited prognostic value of preoperative
91. Stott SL, Lee RJ, Nagrath S, Yu M, Miyamoto DT, Ulkus L, Inserra circulating tumor cells for early biochemical recurrence in patients
EJ, Ulman M, Springer S, Nakamura Z, Moore AL, Tsukrov DI, with localized prostate cancer. Urol Oncol 2016;34:235.e11-6.
Kempner ME, Dahl DM, Wu CL, Iafrate AJ, Smith MR, Tompkins 102. Murray NP, Aedo S, Fuentealba C, Jacob O, Reyes E, Novoa C,
RG, Sequist LV, Toner M, Haber DA, Maheswaran S. Isolation and Orellana S, Orellana N. Limited improvement of incorporating
characterization of circulating tumor cells from patients with localized primary circulating prostate cells with the CAPRA score to predict
and metastatic prostate cancer. Sci Transl Med 2010;2:25ra23. biochemical failure-free outcome of radical prostatectomy for prostate
92. Fizazi K, Morat L, Chauveinc L, Prapotnich D, De Crevoisier R, cancer. Urol Oncol 2016;34:430.e17-25.

462 Journal of Cancer Metastasis and Treatment ¦ Volume 2 ¦ December 16, 2016